The Gross Margin of Taiko Pharmaceutical Co Ltd (4574.T) is 58.26%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 58.26% |
2023-12-31 | 42.11% |
2022-12-31 | 21.41% |
2021-12-31 | 29.44% |
2020-12-31 | 70.07% |
2020-03-31 | 70.88% |
2019-03-31 | 69.13% |
2018-03-31 | 69.49% |
2017-03-31 | 67.28% |
2016-03-31 | 69.30% |